Angiogenesis treatment, new concepts on the horizon

Angiogenesis. 2006;9(2):67-72. doi: 10.1007/s10456-006-9031-3. Epub 2006 Sep 9.

Authors

Robert J Griffin¹, Grietje Molema, Ruud P M Dings

Affiliation

¹ Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, Minneapolis, MN 55455, USA.

PMID: 16964528
DOI: 10.1007/s10456-006-9031-3

No abstract available

Publication types

Congress

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal / therapeutic use
Concept Formation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Interleukin-2 / therapeutic use
Interleukin-8 / therapeutic use
Neovascularization, Pathologic / drug therapy*
Tumor Necrosis Factor-alpha / therapeutic use
Vascular Endothelial Growth Factor A / therapeutic use

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Interleukin-2
Interleukin-8
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A